The Royal Liverpool & Broadgreen University Hospitals NHS Trust wins innovation award to improve quality of health care

A team from The Royal Liverpool & Broadgreen University Hospitals NHS Trust (RLBUHT) has been selected by the Health Foundation, an independent health care charity, to be part of its £1.5 million innovation programme, Innovating for Improvement.

The third round of the Innovating for Improvement programme is supporting twenty health care projects in the UK with the aim of improving health care delivery and/or the way people manage their own health care by testing and developing innovative ideas and approaches and putting them into practice.

The initiative from the Dialysis Unit at The Royal Liverpool & Broadgreen University Hospitals NHS Trust aims to implement a new nurse-led approach to providing improved, personalised, coordinated, multi-disciplinary care in new haemodialysis patients. Commencing haemodialysis is a time of significant risk, and patients experience high levels of physical and psychological distress. This project will involve testing a new nurse-led pathway that will provide patients with better coordinated, personalised treatment plans, with the overall aim of improving the patient experience and of reducing the mortality rate of patients starting haemodialysis.

Over the course of the programme the team will develop its innovative idea and approach, put it into practice and gather evidence about how the innovation improves the quality of health care.

The team will be led by Dr Asheesh Sharma, who will work closely with Sister Vicky Ashworth to deliver the project. 2Bio Ltd’s Impact Science Team provides innovation services to RLBUHT and has supported the development of this project from a very early stage.

Dr Sharma, Consultant Nephrologist and Innovation Lead, RLBUHT said, “ Having recognised the potential to improve the quality of care for this vulnerable group of patients, we are really pleased to have secured this award and now look forward to implementing our ideas. We have pulled together a strong team to deliver this project that involves our nursing team, the clinicians, our patients, our Service Improvement & Excellence Team, data analysis expertise from our Business Intelligence Team and support from our Innovation Support Team provided by 2Bio Ltd. We can’t wait to start making a difference for our patients.”

Dr Charley Ward, Senior Business Consultant at 2Bio said, “We are delighted that this award has been made, it is a great outcome for all the hard work the team has put in so far. We’re looking forward to getting on with the task to make sure that patients at RLBUHT and nationally will benefit from this important innovation in dialysis care.”

Sarah Henderson, Associate Director from the Health Foundation said, “We are very excited to be working with such a high-calibre of teams, who all have great innovative ideas. As an organisation we are keen to support innovation at the frontline across all sectors of health and care services, and I am pleased that we will be able to support these ambitious teams to develop and test their ideas over the next year. “Our aim is to promote the effectiveness and impact of the teams’ innovations and show how they have succeeded in improving the quality of healthcare, with the intention of these being widely adopted across the UK.”

The programme will run for fifteen months and each project will receive up to £75,000 of funding to support the implementation and evaluation of the project.


Contact at the Health Foundation:

Navdeep Sidhu, Marketing and Communications Manager T: 020 7257 8067 E:

Mike Findlay, Media Manager T: 0207 257 E:

Notes to editors: About the Health Foundation The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK.

Our aim is a healthier population, supported by high quality health care that can be equitably accessed. We learn what works to make people’s lives healthier and improve the health care system. From giving grants to those working at the front line to carrying out research and policy analysis, we shine a light on how to make successful change happen.

We make links between the knowledge we gain from working with those delivering health and health care and our research and analysis. Our aspiration is to create a virtuous circle, using what we know works on the ground to inform effective policymaking and vice versa. We believe good health and health care are key to a flourishing society. Through sharing what we learn, collaborating with others and building people’s skills and knowledge, we aim to make a difference and contribute to a healthier population.

UK Government minister launches Impact Data Metrics Report

16th July 2015 – Mapping Innovation Report released.

Today, the UK Minister of State for Universities and Science, Jo Johnson MP,  announced the publication of ‘Mapping Local Comparative Advantage in Innovation’ when he spoke at the University of Sheffield’s Advanced Manufacturing Research Centre. The main theme of his speech was the UK Government’s commitment to boost collaboration between business and universities as part of a bold and ambitious plan called One Science Nation.

2Bio’s Impact Data Metrics team, are co-authors of ‘Mapping Local Comparative Advantage in Innovation’ together with partners at the European Institute for Urban Affairs. This research has established a comprehensive framework for innovation indicators, and using our Impact Data Metrics platform, has added new datasets for the UK’s Local Economic Partnerships (LEPs) to build their future innovation strategies upon.

Geoff Wainwright of Impact Data Metrics said, “This was a fascinating piece of work to undertake and we were fortunate enough to work with a great team from the European Institute of Urban Affairs at Liverpool John Moores University, as well as colleagues from UK Departmernt of Business, Innovation & Skills. We analysed hundreds of thousands of data points to build very accurate and comprehensive maps of research, business and innovation activity across LEPs. This data is now finding real practical applications in providing detailed intelligence to support the building of plans for business growth, partnering and inward investment, and identifying key infrastructure requirements to support each LEP in realising their full growth potential. The range, depth and quality of the research activity we discovered was awe inspiring, and whilst we were only able to publish a high-level view of the data, we have continued to review, and keep current, the deep detail in the records for each LEP. We are seeing relationships and opportunities that will provide valuable starting points for analysis and planning. We are describing the knowledge economy of these areas in the same way as consumer activity is tracked.”

For more information on the capability of the Impact Data Metrics Platform, please contact:

Dr Geoff Wainwright
Tel. +44 (0)151 795 4100

For details of the Minister’s speech, please see:

To access the report, please see:


2Bio Ltd. is pleased to announce that it has entered into a partnership with IBMC – Instituto de Biologia Molecular e Celular – to manage and commercialise its Intellectual property.

IBMC is a multidisciplinary research institution that brings together researchers working within the University of Porto, and affiliated hospitals, to produce a unique environment for research in the life sciences; it is recognised and funded by the Foundation for Science and Technology (FCT) of Portugal; the main Portuguese government body that funds science.

2Bio’s Impact Science Team will be deployed to evaluate technologies for their commercial potential, create commercialisation strategies and develop new business value for IBMC.

The work will also encompass all aspects of IP protection and management, integrating with IBMC’s own Tech Transfer Office.

The Impact Science Team has a strong track record of IP and market analysis in the life sciences sector, and has supported the creation of new business value for a wide range of international clients. The team has worked together for more than 10 years and draws on both science and business expertise in a wide range of disciplines.

Dr. Rhys Roberts, 2Bio’s co-founder said “this important strategic partnership gives 2Bio the opportunity to work seamlessly with the outputs of IBMC’s research excellence; we expect to identify and deliver valuable business outcomes for IBMC, and provide channels to reach global markets. We have been very impressed with what we have seen so far, from both the research and the leadership at the Institute”.

Professor Claudio Sunkel, IBMC Director, said “This partnership with 2Bio is the start of a new approach to explore Technology Transfer within our institute and we are all very excited to begin the process of detailed exploration of the technologies developed at our institute. IBMC’s main research interests are in the areas of Neurodegenerative diseases, Host-Pathogen Interactions and various aspects of Molecular and Cellular Biology related to Cell Division and Cancer.  We are confident that this partnership will be crucial in finding the appropriate routes for the commercialization of our human-related work, as well as our proven model organisms including mouse models”